Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT00624286

Public ClinicalTrials.gov record NCT00624286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Indacaterol (150 μg o.d.) in Patients With Chronic Obstructive Pulmonary Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study was designed to provide 12 weeks efficacy and safety data of the 150 μg once-daily (od) dose of indacaterol in chronic obstructive pulmonary disease (COPD).

Study identification

NCT ID
NCT00624286
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis
Industry
Enrollment
416 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jun 30, 2008
Completion
Jun 30, 2008
Last update posted
Aug 17, 2011

2008

United States locations

U.S. sites
118
U.S. states
37
U.S. cities
108
Facility City State ZIP Site status
Novartis Investigative Site Anniston Alabama 36207-5710
Novartis Investigative Site Birmingham Alabama 35209-6870
Novartis Investigative Site Jasper Alabama 35501
Novartis Investigative Site Mobile Alabama 36608-6705
Novartis Investigator Site Glendale Arizona 85306
Novartis Investigative Site Phoenix Arizona 85006-2611
Novartis Investigative Site Phoenix Arizona 85013-4232
Novartis Investigative Site Tucson Arizona 85712
Novartis Investigative Site Tucson Arizona 85723
Novartis Investigative Site Pine Bluff Arkansas 71603
Novartis Investigative Site Buena Park California 90620
Novartis Investigative Site Encinitas California 92024-1332
Novartis Investigative Site Fresno California 93710
Novartis Investigative Site Fullerton California 92835
Novartis Investigative Site Los Angeles California 90048
Novartis Investigative Site Orange California 92869
Novartis Investigative Site Palmdale California 93551-1411
Novartis Investigative Site Riverside California 92506
Novartis Investigative Site San Jose California 95117
Novartis Investigative Site San Mateo California 94401
Novartis Investigative Site Stockton California 95207
Novartis Investigative Site Torrance California 90503
Novartis Investigative Site Vista California 92083
Novartis Investigative Site Walnut Creek California 94598
Novartis Investigative Site Fort Collins Colorado 80528-3400
Novartis Investigative Site Golden Colorado 80401
Novartis Investigator Site Wheat Ridge Colorado 80033-4300
Novartis Investigative Site Newark Delaware 19713
Novartis Investigative Site Clearwater Florida 33765
Novartis Investigative Site Largo Florida 33770-2335
Novartis Investigative Site Ocala Florida 34471
Novartis Investigative Site Pensacola Florida 32503
Novartis Investigative Site Pensacola Florida 32504-8756
Novartis Investigative Site Pensacola Florida 32504
Novartis Investigative Site Rockledge Florida 32955
Novartis Investigator Site Sarasota Florida 34233-1272
Novartis Investigative Site South Miami Florida 33143
Novartis Investigative Site Tamarac Florida 33321
Novartis Investigative Site Tampa Florida 33603
Novartis Investigative Site Zephyrhills Florida 33542-7505
Novartis Investigative Site Atlanta Georgia 30342
Novartis Investigative Site Austell Georgia 30106-1110
Novartis Investigative Site Normal Illinois 61761
Novartis Investigative Site O'Fallon Illinois 62269
Novartis Investigative Site River Forest Illinois 60305
Novartis Investigative Site Indianapolis Indiana 46285
Novartis Investigative Site Ames Iowa 50010
Novartis Investigative Site Iowa City Iowa 52240
Novartis Investigative Site Shawnee Kansas 66216-1800
Novartis Investigative Site Crescent Springs Kentucky 41017
Novartis Investigative Site Lexington Kentucky 40504
Novartis Investigative Site Madisonville Kentucky 42431
Novartis Investigative Site Metairie Louisiana 70006-4225
Novartis Investigative Site Opelousas Louisiana 70570
Novartis Investigative Site Slidell Louisiana 70458
Novartis Investigative Site Worcester Massachusetts 01605
Novartis Investigative Site Ann Arbor Michigan 48105-9755
Novartis Investigative Site Clarkston Michigan 48346
Novartis Investigative Site Flint Michigan 58532
Novartis Investigative Site Livonia Michigan 48152
Novartis Investigative Site Troy Michigan 48085
Novartis Investigator Site Edina Minnesota 55435
Novartis Investigative Site Minneapolis Minnesota 55407
Novartis Investigative Site Saint Charles Missouri 63301-2847
Novartis Investigator Site St Louis Missouri 63141
Novartis Investigative Site Kalispell Montana 59901
Novartis Investigative Site Missoula Montana 59808
Novartis Investigative Site Lincoln Nebraska 68510
Novartis Investigative Site Omaha Nebraska 68114-3570
Novartis Investigative Site Omaha Nebraska 68134
Novartis Investigative Site Henderson Nevada 89014
Novartis Investigative Site Las Vegas Nevada 89102-4508
Novartis Investigative Site Cherry Hill New Jersey 08003
Novartis Investigative Site Summit New Jersey 07901
Novartis Investigative Site Cortland New York 13045
Novartis Investigative Site Rochester New York 14618
Novartis Investigative Site Charlotte North Carolina 28207
Novartis Investigative Site Charlotte North Carolina 28277
Novartis Investigative Site High Point North Carolina 27262-4320
Novartis Investigative Site Shelby North Carolina 28150
Novartis Investigative Site Cincinnati Ohio 45227
Novartis Investigative Site Cincinnati Ohio 45231
Novartis Investigator Site Cincinnati Ohio 45242
Novartis Investigative Site Columbus Ohio 43213
Novartis Investigative Site Columbus Ohio 43215
Novartis Investigative Site Marion Ohio 43302
Novartis Investigative Site Thornville Ohio 43076-8010
Novartis Investigative Site Oklahoma City Oklahoma 73112
Novartis Investigative Site Tulsa Oklahoma 74135-2920
Novartis Investigative Site Eugene Oregon 97404
Novartis Investigative Site Medford Oregon 97504-9741
Novartis Investigative Site Portland Oregon 97213
Novartis Investigative Site Erie Pennsylvania 15608
Novartis Investigative Site Homestead Pennsylvania 15120
Novartis Investigative Site Pittsburgh Pennsylvania 15243-1800
Novartis Investigative Site Cumberland Rhode Island 02864
Novartis Investigative Site Charleston South Carolina 29412
Novartis Investigative Site Gaffney South Carolina 29340
Novartis Investigative Site Greenville South Carolina 29615
Novartis Investigative Site North Charleston South Carolina 29406-9167
Novartis Investigative Site Spartanburg South Carolina 29303
Novartis Investigative Site Union South Carolina 29379
Novartis Investigative Site Johnson City Tennessee 37601
Novartis Investigative Site Amarillo Texas 79106
Novartis Investigative Site El Paso Texas 79902-5107
Novartis Investigative Site Fort Worth Texas 76104-4185
Novartis Investigative Site New Braunfels Texas 78130-6113
Novartis Investigative Site San Antonio Texas 78229
Novartis Investigative Site Payson Utah 84651
Novartis Investigative Site Abingdon Virginia 24210-2921
Novartis Investigative Site Lynchburg Virginia 24501
Novartis Investigative Site Richmond Virginia 23229
Novartis Investigative Site Richmond Virginia 23298
Novartis Investigative Site Spokane Washington 99201
Novartis Investigative Site Spokane Valley Washington 99216-1092
Novartis Investigative Site Tacoma Washington 98405
Novartis Investigative Site Morgantown West Virginia 26505-2713
Novartis Investigative Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00624286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2011 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00624286 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →